A key Senate committee on Wednesday launched an investigation into how Novo Nordisk (NVO) (OTCPK:NONOF) prices its popular weight loss drug semaglutide in the U.S. Sen. Bernie Sanders (I-Vt.), ...

Lars Jørgensen will testify on a solo panel before the Senate Committee on Health, Education, Labor, and Pensions, Bernie ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who can’t get the blockbuster drug through insurance.

Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate hearing later this ... Labor and Pensions (HELP) committee hearing in early September.

In September, the Senate Health Committee grilled Novo Nordisk CEO Lars Fruergaard Jørgensen over why Wegovy and Ozempic cost hundreds of dollars less per month in countries such as France ...

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular ...

The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes ... recommendation from the US FDA Advisory Committee in November 2012. President Trump has ...